RJF-PB: the cashflow

MyFinsight

For the year ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Net revenues	1,814	-	-	-
Total non-interest expenses	263	-	-	-
Pre-tax income before equity in undistributed net income of subsidiaries	1,551	-	-	-
Income tax benefit	-83	-	-	-
Income before equity in undistributed net income of subsidiaries	1,634	-	-	-
Equity in undistributed net income of subsidiaries	501	-	-	-
Net income	2,135	2,068	1,739	1,509
Depreciation and amortization	195	179	165	145
Deferred income taxes, net	-52	-83	-88	-16
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gain/loss on other investments	-	-	-	-23
Premium and discount amortization on available-for-sale securities and bank loans and net unrealized gains/losses on other investments	19	36	49	-
Provisions for credit losses and legal and regulatory matters	122	21	292	111
Share-based compensation expense	254	254	237	192
Unrealized gains on corporate-owned life insurance policies, net of expenses	133	233	96	-174
Losses on extinguishment of debt	-	-	0	0
Other	-39	-22	-10	-49
Assets segregated for regulatory purposes excluding cash and cash equivalents	-	0	0	-2,100
Collateralized agreements, net of collateralized financings	-223	-270	-157	37
Loans provided to financial advisors, net of repayments	-	-	-	120
Loans (provided to) financial advisors, net of repayments	328	223	7	-
Brokerage client receivables and other receivables, net	106	362	-257	203
Trading instruments, net	145	34	33	-48
Derivative instruments, net	-46	151	130	-479
Other assets	-119	-9	52	126
Brokerage client payables and other payables	7	91	-6,088	-4,213
Accrued compensation, commissions and benefits	279	404	123	-76
Purchases and originations of loans held for sale, net of proceeds from sales of securitizations and loans held for sale	202	41	-49	-33
Net cash provided by/(used in) operating activities	2,434	2,155	-3,514	72
Increase in bank loans, net	5,711	2,599	1,262	7,235
Proceeds from sales of loans held for investment	245	415	680	213
Purchases of available-for-sale securities	582	503	611	3,069
Available-for-sale securities maturations, repayments and redemptions	1,976	2,010	1,262	1,712
Proceeds from sales of available-for-sale securities	78	0	0	52
Cash and cash equivalents acquired in business acquisitions, including those segregated for regulatory purposes, net of cash paid for acquisitions	-	0	0	-1,461
Additions to property and equipment	188	205	173	91
Purchase of federal reserve bank stock	-	-	22	-
Purchases of federal home loan bank stock, net	-	-	4	-
Sales/(purchases) of federal reserve bank (frb) and federal home loan bank (fhlb) stock, net	-11	0	-	-
Investment in note receivable	-	0	0	125
Investment in solar tax credit equity investment	-	-	69	-
Renewable energy tax credit equity investments	20	42	-	-
(purchases)/sales of other investments, net	-	-	-	-24
Sales/(purchases) of other investments, net	73	-20	6	-
Other investing activities, net	57	64	69	93
Net cash used in investing activities	-4,321	-968	-274	-7,151
Proceeds from senior notes issuances, net of debt issuance costs paid	-	-	0	0
Extinguishment of senior notes payable	-	-	0	0
Increase in bank deposits	2,887	1,811	2,842	6,269
Repurchases of common stock and share-based awards withheld for payment of withholding tax requirements	1,267	984	862	216
Dividends on common and preferred stock	416	383	355	277
Exercise of stock options and employee stock purchases	31	46	46	52
Redemption of preferred stock	0	0	40	-
Proceeds from senior notes issuance, net of debt issuance costs paid	1,480	-	-	-
Redemption of subordinated notes	98	-	-	-
Proceeds from fhlb advances	750	1,300	3,200	1,025
Repayments of fhlb advances and other borrowed funds	-	1,350	3,391	-
Repayments of fhlb advances	1,000	-	-	967
Other financing, net	-6	-2	-2	-7
Net cash provided by financing activities	2,361	438	1,438	5,879
Effect of exchange rate changes on cash and cash equivalents, including those segregated for regulatory purposes	-35	175	239	-590
Net increase/(decrease) in cash and cash equivalents, including those segregated for regulatory purposes and restricted cash	439	1,800	-2,111	-1,790
Cash and cash equivalents at beginning of period	14,348	12,548	14,659	16,449
Cash and cash equivalents at end of period	14,787	14,348	12,548	14,659

Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

RJF-PB: the cashflow